< back
15.04.13
Green Biologics announces election of Dr. Tim Davies as President of the Society for Industrial Microbiology and Biotechnology
Abingdon, Oxfordshire U.K. (April 15, 2013):
Green Biologics Limited (GBL), a UK-based industrial biotechnology company announces the election of Dr. Tim Davies, GBL’s Chief Technology Officer, as President of the Society for Industrial Microbiology and Biotechnology. Dr. Davies has been a director of SIMB since 2010.
The Society for Industrial Microbiology and Biotechnology is a nonprofit, international association dedicated to the advancement of microbiological sciences, especially as they apply to industrial products, biotechnology, materials, and processes. Founded in 1949, SIMB promotes the exchange of scientific information through its meetings and publications, and serves as liaison among the specialized fields of microbiology. Membership in the Society is extended to all scientists and companies in the general field of microbiology.
Dr. Davies joined GBL as Chief Technology Officer in 2011 after having served as a board advisor since 2004. “I’m personally delighted that Tim’s vision and leadership skills have been recognized by SIMB and have no doubt of his ability to guide and lead this outstanding organization,” said Sean Sutcliffe, Chief Executive of GBL. “These qualities have been long recognized by those of us who have worked so closely with Tim over these past critical years of growth at Green Biologics.”
Dr. Davies will act as President elect from August 2013 and will begin his term as President of SIMB in August, 2014 serving through 2015 and will continue to serve on the SIMB board as Past-President through 2016.
About Green Biologics
GBL is a privately held industrial biotechnology company based in Abingdon, Oxfordshire, UK specializing in the manufacture of renewable chemicals and advanced biofuels. The company’s core focus is n-butanol, a chemical precursor for paints, coatings, adhesives, inks, plastics, pharmaceuticals, household cleaners and personal care ingredients with a 4.5 million tonne global market worth $10 billion. GBL is the global technology leader in renewable n-butanol and has developed advanced fermentation technology to produce renewable chemicals from non-edible cellulosic feedstocks such as agricultural and forestry residuals and municipal solid wastes. GBL has laboratory and production facilities in the U.K. and the U.S. and operates globally in Europe, China, North America, India and Brazil. For more information please visit www.greenbiologics.com.
Contact Information:
Green Biologics Limited
Samantha Jeskins – +44 1235 435710
[email protected]